Murray Stahl's CME Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 276.8K shares of CME Group Inc. (CME) worth $74.78 M, representing 0.91% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Murray Stahl has maintained a long-term strategic position in CME, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2017, adding 204.5K shares. Largest reduction occurred in Q2 2024, reducing 58.8K shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Murray Stahl
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +81,934 | Add 0.00% | 81,933 | $75.95 |
| Q3 2013 | -2,447 | Reduce 2.99% | 79,486 | $73.87 |
| Q4 2013 | -431 | Reduce 0.54% | 79,055 | $78.46 |
| Q1 2014 | -1,056 | Reduce 1.34% | 77,999 | $74.01 |
| Q2 2014 | -4,730 | Reduce 6.06% | 73,269 | $70.96 |
| Q3 2014 | -1,170 | Reduce 1.60% | 72,099 | $79.96 |
| Q4 2014 | -73 | Reduce 0.10% | 72,026 | $88.65 |
| Q2 2015 | -400 | Reduce 0.56% | 71,626 | $93.05 |
| Q3 2015 | -11,990 | Reduce 16.74% | 59,636 | $92.75 |
| Q4 2015 | -48,760 | Reduce 81.76% | 10,876 | $90.57 |
| Q1 2016 | -1,260 | Reduce 11.59% | 9,616 | $95.99 |
| Q3 2016 | -1 | Reduce 0.01% | 9,615 | $104.52 |
| Q1 2017 | +6 | Add 0.06% | 9,621 | $118.80 |
| Q2 2017 | -165 | Reduce 1.71% | 9,456 | $125.21 |
| Q4 2017 | +204,542 | Add 2163.09% | 213,998 | $146.05 |
| Q1 2018 | +8,924 | Add 4.17% | 222,922 | $161.74 |
| Q2 2018 | +4,595 | Add 2.06% | 227,517 | $163.92 |
| Q3 2018 | -4,230 | Reduce 1.86% | 223,287 | $170.21 |
| Q4 2018 | +2,744 | Add 1.23% | 226,031 | $188.12 |
| Q1 2019 | +217,827 | Add 0.00% | 217,826 | $164.58 |
| Q2 2019 | -9,563 | Reduce 4.39% | 208,263 | $194.11 |
| Q3 2019 | -3,637 | Reduce 1.75% | 204,626 | $211.34 |
| Q4 2019 | -8,211 | Reduce 4.01% | 196,415 | $200.72 |
| Q1 2020 | -7,972 | Reduce 4.06% | 188,443 | $172.91 |
| Q2 2020 | -5,838 | Reduce 3.10% | 182,605 | $162.54 |
| Q3 2020 | -11,541 | Reduce 6.32% | 171,064 | $167.31 |
| Q4 2020 | -18,164 | Reduce 10.62% | 152,900 | $182.05 |
| Q1 2021 | +7,738 | Add 5.06% | 160,638 | $204.23 |
| Q2 2021 | +39,478 | Add 24.58% | 200,116 | $212.68 |
| Q3 2021 | +2,008 | Add 1.00% | 202,124 | $193.38 |
| Q4 2021 | +8,798 | Add 4.35% | 210,922 | $228.46 |
| Q1 2022 | +34,753 | Add 16.48% | 245,675 | $237.86 |
| Q2 2022 | +18,474 | Add 7.52% | 264,149 | $204.70 |
| Q3 2022 | -11,987 | Reduce 4.54% | 252,162 | $177.13 |
| Q4 2022 | -7,488 | Reduce 2.97% | 244,674 | $168.16 |
| Q1 2023 | -4,087 | Reduce 1.67% | 240,587 | $191.52 |
| Q2 2023 | -9,160 | Reduce 3.81% | 231,427 | $185.29 |
| Q3 2023 | -11,451 | Reduce 4.95% | 219,976 | $200.22 |
| Q4 2023 | -19,246 | Reduce 8.75% | 200,730 | $210.60 |
| Q1 2024 | -1,330 | Reduce 0.66% | 199,400 | $215.29 |
| Q2 2024 | -58,788 | Reduce 29.48% | 140,612 | $196.60 |
| Q3 2024 | -11,899 | Reduce 8.46% | 128,713 | $220.65 |
| Q4 2024 | -2,860 | Reduce 2.22% | 125,853 | $232.23 |
| Q1 2025 | +2,400 | Add 1.91% | 128,253 | $265.29 |
| Q2 2025 | -855 | Reduce 0.67% | 127,398 | $275.62 |
| Q3 2025 | +149,375 | Add 117.25% | 276,773 | $270.19 |
Murray Stahl's CME Group Investment FAQs
Murray Stahl first purchased CME Group Inc. (CME) in Q2 2013, acquiring 81,933 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held CME Group Inc. (CME) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl's largest addition to CME Group Inc. (CME) was in Q1 2019, adding 217,826 shares worth $35.85 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 276,773 shares of CME Group Inc. (CME), valued at approximately $74.78 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CME Group Inc. (CME) represents approximately 0.91% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl's peak holding in CME Group Inc. (CME) was 276,773 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.